Production (Stage)
Trinity Biotech plc
TRIB
$0.6341
-$0.0374-5.57%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -16.96M | -6.76M | -5.50M | -6.72M | -8.95M |
| Total Depreciation and Amortization | 426.00K | 153.00K | 460.00K | 229.00K | 744.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.46M | 3.83M | 2.99M | 4.16M | 8.72M |
| Change in Net Operating Assets | 6.42M | 1.67M | 2.29M | -2.33M | 153.00K |
| Cash from Operations | 3.35M | -1.10M | 242.00K | -4.66M | 676.00K |
| Capital Expenditure | -157.00K | -72.00K | -250.00K | -128.00K | -321.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | -- | -- |
| Other Investing Activities | -2.58M | -3.10M | -641.00K | -758.00K | -1.00M |
| Cash from Investing | -2.74M | -3.17M | -891.00K | -886.00K | -1.32M |
| Total Debt Issued | 2.00M | 6.50M | 0.00 | -- | -- |
| Total Debt Repaid | -665.00K | -603.00K | -555.00K | -571.00K | -684.00K |
| Issuance of Common Stock | 545.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.00K | -1.98M | -1.21M | -1.86M | -1.69M |
| Cash from Financing | 1.81M | 3.92M | -1.76M | -2.43M | -2.37M |
| Foreign Exchange rate Adjustments | -92.00K | -108.00K | -158.00K | 14.00K | -179.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.33M | -459.00K | -2.57M | -7.97M | -3.20M |